Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.110
+0.050 (2.43%)
At close: Aug 14, 2026, 4:00 PM EDT
2.140
+0.030 (1.42%)
After-hours: Aug 14, 2026, 4:10 PM EDT
Lipocine Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lipocine stock have an average target of $6.00, which predicts a 184.36% increase from the current stock price of 2.11.
Price Target: $6.00 (+184.36%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lipocine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $6 | Buy | Maintains | $6 | +184.36% | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 6, 2026 |
Financial Forecast
Revenue This Year
753.50K
from 1.98M
Decreased by -61.88%
Revenue Next Year
1.09M
from 753.50K
Increased by 44.66%
EPS This Year
9.01
EPS Next Year
10.03
from 9.01
Increased by 11.32%
EPS and Forward PE are based on non-GAAP adjusted numbers.